Introduction
iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at the interface of precision cancer medicine and digital health, with the aim of advancing research and providing innovative solutions to tackle cancer.
iCAN News and Events
iCAN Science Seminar on Development of functional precision medicine for patient with CLL with Dr Skånland
Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in Europe and it remains incurable. It is a…
New director appointed to lead the iCANDOC pilot programme
We are pleased to announce the appointment of Mariike Kuijjer, who took on the role of Director of the iCANDOC…
iCAN Science Seminar on Epigenomic evolution of breast cancers at single-cell resolution with Dr Céline Vallot
Welcome to the iCAN science seminar with Dr. Céline Vallot (Institut Curie, CNRS) on Epigenomic evolution of breast cancers at single-cell…
iCAN in Numbers
iCAN Study Participants
Company collaborations
iCAN Publications
Invention
Disclosures
Patents
External Funding
